0001477932-21-001491.txt : 20210317 0001477932-21-001491.hdr.sgml : 20210317 20210317163551 ACCESSION NUMBER: 0001477932-21-001491 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210316 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210317 DATE AS OF CHANGE: 20210317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OBITX, Inc. CENTRAL INDEX KEY: 0001730869 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 821091922 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-56142 FILM NUMBER: 21751028 BUSINESS ADDRESS: STREET 1: 3027 US HIGHWAY 17 CITY: FLEMING ISLAND STATE: FL ZIP: 32003 BUSINESS PHONE: 321-802-2474 MAIL ADDRESS: STREET 1: 3027 US HIGHWAY 17 CITY: FLEMING ISLAND STATE: FL ZIP: 32003 8-K 1 obitx_8k.htm FORM 8-K obitx_8k.htm

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

  

CURRENT REPORT

Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 16, 2021

 

Commission File Number: 000-56142

 

OBITX, INC.

(Exact name of registrant as specified in charter)

 

DELAWARE

 

82-1091922

(State or other jurisdiction

of incorporation)

 

(IRS Employer

Identification No.)

 

 

 

3027 US HIGHWAY 17, FLEMING ISLAND, FL

 

32003

(Address of principal executive offices)

 

(Zip Code)

  

Registrant’s telephone number 321-802-2474

   

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

 

☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

 

☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

 

 

 

 

 

As used in this report, the terms “Company,” “our company,” “us,” “OBITX,”, “we” and “our” refer to OBITX, Inc. unless the context requires otherwise

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On March 16, 2021, the Board of Directors of the Company appointed Robert Adams as the Chief Technology Officer of the Company, effective immediately.

 

Mr. Adams has been a member of the OBITX Board of Directors since 2020 where he served on the audit and compensation committees. He had been working in the blockchain and cryptocurrency markets since 2015. He was an early adopter of Bitcoin and Ethereum.

 

Mr. Adams recently served as the Technology Director for Blue Cross/Blue Shield of Florida with its headquarters in Jacksonville, Florida. While employed there he managed a budget more than $100 million per year with more than 45,000 employees. He left his employment with Blue Cross/Blue Shield of Florida to further his entrepreneurial spirit within the blockchain and cryptocurrency markets.

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit

 

Description

 

 

 

99.1

 

Press release dated March 16, 2021.

  

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

 

    OBITX, INC.  

 

 

 

 

Date: March 17, 2021

By: /s/ Eric Jaffe

 

 

Eric Jaffe

 
   

Chief Executive Officer

 

  

 

 

3

 

EX-99.1 2 obitx_ex991.htm PRESS RELEASE obitx_ex991.htm

EXHIBIT 99.1

    

March 16, 2021

 

OBITX Announces Robert Adams Chief Technology Officer

 

OBITX, Inc., (OTCMKTS: OBTX), an advanced software development and services company specializing in blockchain technologies and decentralized processing, announced today the selection of Robert “Eddie” Adams as the company’s Chief Technology Officer.  Mr. Adams recently served as the Technology Director for Blue Cross/Blue Shield of Florida with its headquarters in Jacksonville, Florida.  While employed there he managed a budget more than $100 million per year with more than 45,000 employees. He left his employment with Blue Cross/Blue Shield of Florida to further his entrepreneurial spirit within the blockchain and cryptocurrency markets.  Prior to his employment with Blue Cross/Blue Shield of Florida he  was the supervisor of information systems with the School District of Clay County.

 

Mr. Adams had been working in the blockchain and cryptocurrency markets since 2015.  He was an early adopter of Bitcoin and Ethereum.  He has participated in the development of two additional blockchains.

 

Mr. Adams has been a member of the OBITX Board of Directors since 2020 where he served on the audit and compensation committees. 

 

“As my role expands with OBITX, I am confident this team will excel.  This team brings a level of maturity to an infant industry poised for rapid expansion and growth,” said Robert Adams. Eric Jaffe, OBITX CEO went on to state, “Eddie is a proven asset for OBITX.  We are going to tap into his expertise and utilize his skill set to capsulate our path to success.  His initial involvement will begin with the expansion of our mining and staking operations in the blockchain and cryptocurrency markets.”

 

Contact: Eric Jaffe

           info@obitx.com

 

About OBITX:

 

Headquartered in Fleming Island, Florida, OBITX, Inc., (OTCQB: OBTX) is a development,  consulting and services organization specializing in blockchain technologies and decentralized processing.

 

Forward Looking Statements

 

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.